Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Keep Reading →
May 22 - News
Throughout this month, investors have focused largely on the possibility that the Federal Reserve would start to ease off the throttle in providing accommodative monetary policy...
Keep Reading →
May 22 - News
The study tracked men with ADHD for more than 30 years and found that a whopping 41% of them were obese compared to 22% of patients in a matched control group who didn't have ...
Keep Reading →
May 22 - News
We dread some checkups. Some people even put them off. If you own Pfizer Inc. (NYSE:PFE) stock, though, there's no need for dread or delay.
Keep Reading →
May 21 - News
Let's face it; we all dislike stress, but it's something we all live with to some degree.
Keep Reading →
May 21 - News
One of Pfizer Inc. (NYSE:PFE)'s best selling drugs is Viagra, which is used to treat erectile dysfunction.
Keep Reading →
May 21 - News
Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise...
Keep Reading →
May 20 - News
Whether or not you've been keeping tabs, the American Society of Clinical Oncology's annual meeting is less than two weeks away.
Keep Reading →
May 20 - News
There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.
Keep Reading →
May 20 - News
Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable.
Keep Reading →
May 20 - News
As I noted 11 weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
May 20 - News
Avastin -- which the Food and Drug Administration has approved to treat metastatic colorectal cancer (as a first-line and second-line treatment), metastatic HER2-negative breast...
Keep Reading →
May 19 - News
Nearly 400 former workers at Pfizer Inc.
Keep Reading →
May 17 - News
Alzheimer's is a debilitating neurodegenerative disorder affecting approximately 5 million Americans, yet its causes are remarkably enigmatic. Nonetheless, pharma and biotech...
Keep Reading →
May 17 - News
Editor's Note: Related tickers: General Electric Company (NYSE:GE), Pfizer Inc. (NYSE:PFE), Apple Inc. (NASDAQ:AAPL), Time Warner Inc (NYSE:TWX), The Home Depot, Inc.
Keep Reading →
May 17 - Hedge Funds
Investors emphasize the "bio" in biotech a great deal. We look at how much patients' health improved in clinical trials.
Keep Reading →
May 16 - News
I admit to not being a big fan of many of her movies -- possibly the only man on the planet who will admit so -- but there's little denying that movie sensation Angelina Jolie...
Keep Reading →
May 16 - News
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has been on a solid run since early last year and it has continued to climb to new highs this year as well.
Keep Reading →
May 15 - News
Many stocks within the pharmaceutical industry have rallied significantly over the past few years and now sit at multi-year highs.
Keep Reading →
May 15 - News
Pfizer Inc. (NYSE:PFE) stock has been a boon for growth investors over the past year.
Keep Reading →
May 15 - News
Confirmation bias – one of the psychological traps investors can be most prone to falling victim to.
Keep Reading →
May 15 - News
Billionaire Ken Fisher’s Fisher Asset Management has filed its quarterly 13F disclosure with the SEC, presenting its portfolio of equity holdings as of the end of the March ...
Keep Reading →
May 15 - Hedge Funds
Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2.
Keep Reading →
May 14 - News
Pharmaceutical companies in the U.S. are not having it easy these days.
Keep Reading →
May 14 - News
For years, investors have relied on cheap money to fund high stock prices.
Keep Reading →
May 14 - News
Overall, the market is seeing red today. The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is down 36 points as of 11 a.m. EDT, with little momentum to push it higher.
Keep Reading →
May 13 - News
Pfizer Inc. (NYSE:PFE) saw a strong pullback earlier this month, with its stock tumbling over 6% after reporting first-quarter earnings results.
Keep Reading →
May 13 - News
With the SPDR S&P Biotech Index up 32% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
May 13 - News
Charlie Munger offers a valuable nugget of investing advice: "Carefully look at what other great investors have done." Fortunately for us, some of the biggest and brightest investors...
Keep Reading →
May 13 - Hedge Funds
Big pharma isn't the first industry many investors envision when dreaming of the big profits to be made from health care stocks.
Keep Reading →
May 13 - News
As I noted 10 weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
May 12 - News
Even though it was a relatively quiet week in terms of economic data pertaining to the U.S., all of the major indexes posted healthy gains.
Keep Reading →
May 12 - News
Perennial underdog MannKind Corporation (NASDAQ:MNKD) could be on its countdown to liftoff.
Keep Reading →
May 10 - News
Apparently EnerNOC, Inc. (NASDAQ:ENOC)'s first-quarter results didn't do much for investors. The stock sagged after it reported its financial results several days ago.
Keep Reading →
May 10 - News
The first official recognition of Mother's Day occurred nearly a century ago, when on May 9, 1914, President Woodrow Wilson proclaimed the second Sunday in May would thereafter...
Keep Reading →
May 9 - News
The oldest living investment professional, Irving Kahn, 107 years old, has managed to increase the market value of his long holdings by more than 17.8% in the past three months...
Keep Reading →
May 8 - Hedge Funds
Stocks are pushing up into record territory again, although today's gains are of the modest type a day after the Dow Jones Industrial Average closed above 15,000 for the first...
Keep Reading →
May 8 - News
Gilead Sciences, Inc. (NASDAQ:GILD) has exploded over the last few years as a powerhouse of anti-viral medications. Its myriad treatments for HIV have brought in $2 billion...
Keep Reading →
May 8 - News
Reaching the coveted $1 billion mark in annual sales is no small feat for a drug.
Keep Reading →
May 8 - News
Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count).
Keep Reading →
May 7 - News
How I miss the NBC show, "30 Rock". Suave exec Jack Donaghy asks head writer Liz Lemon if she watches CNBC. "No, CNBC gives me a headache.
Keep Reading →
May 7 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) is a pharmaceutical and healthcare company headquartered in the United Kingdom.
Keep Reading →
May 6 - News
As I noted nine weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
May 6 - News
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
Keep Reading →
May 6 - News
If last decade was the "lost decade," then this decade is certainly something of a rebirth for the markets, which have more than doubled off their recession lows.
Keep Reading →
May 5 - News
After receiving news of lower-than-expected jobless claims, higher-than-expected job growth, and interest-rate cuts by the European Central Bank to 0.5%, the U.S.
Keep Reading →
May 4 - News
Merck & Co., Inc. (NYSE:MRK) gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer...
Keep Reading →
May 4 - News
It took a lot longer than many pundits predicted, but we finally hit that ballyhooed mark: Dow 15,000.
Keep Reading →
May 3 - News
The problem was the other drugs didn't make up nearly enough of the Singulair loss.
Keep Reading →
May 3 - News
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Keep Reading →
May 2 - News
